by nms-sync | May 13, 2024 | News
NERVIANO, IT and BOSTON, Mass, May 13, 2024 – Nerviano Medical Sciences S.r.l. (NMS), a part of NMS Group S.p.A. (NMS Group) and Nerviano Medical Sciences, Inc., a wholly owned subsidiary of NMS Group, focused on the discovery and development of oncology drugs...
by nms-sync | Apr 29, 2024 | 2024, News
Nerviano Medical Sciences S.r.l. (NMS), a member of NMS Group S.p.A and a clinical stage biotech discovering and developing innovative therapies for the treatment of cancer, is proud of its participation to the American Association of Cancer Research annual meeting...
by emanuela.scacheri@demo112.axxiem.com | Mar 26, 2024 | 2024, News
Nerviano, IT and Boston, Mass, 26 March, 2024 – Nerviano Medical Sciences S.r.l. (NMS), and Nerviano Medical Sciences, Inc. (NMS-US), a wholly owned subsidiary of NMS S.r.l., focused on the discovery and development of oncology drugs and the largest oncological...
by nms-sync | Mar 8, 2024 | News
Nerviano Medical Sciences S.r.l. (NMS), a member of NMS Group S.p.A and a clinical stage biotech discovering and developing innovative therapies for the treatment of cancer, is proud to announce its participation to the World ADC 2024 summit that will be held in...
by nms-sync | Mar 4, 2024 | News
NERVIANO, IT and BOSTON, Mass, 4 March, 2024 – Nerviano Medical Sciences S.r.l. (NMS), a part of NMS Group S.p.A. (NMS Group) and Nerviano Medical Sciences, Inc. (NMS-US), a wholly owned subsidiary of NMS Group, focused on the discovery and development of...
by nms-sync | Feb 1, 2024 | News
New European Patent Office study: NMS srl top applicant in Italy during the 2002-2021 period
Nerviano, 1 February 2024 The new study “Patents and Innovation against Cancer”, just released today by the European Patent Office (EPO), reports Italy among...
Welcome and Check out our new motion picture!
Recent Comments